Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans

CONTEXT: The gut microbiome is a source of inflammatory factors such as lipopolysaccharide (LPS; endotoxin) that influence metabolic homeostasis. Rifaximin is a well-tolerated antibiotic that may reduce LPS. OBJECTIVE: We sought to develop a method to accurately assess postprandial endotoxemia and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Finlin, Brian S, Zhu, Beibei, Boyechko, Tania, Westgate, Philip M, Chia, Chee W, Egan, Josephine M, Kern, Philip A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691337/
https://www.ncbi.nlm.nih.gov/pubmed/31428718
http://dx.doi.org/10.1210/js.2019-00148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691337/
https://www.ncbi.nlm.nih.gov/pubmed/31428718
http://dx.doi.org/10.1210/js.2019-00148

Ejemplares similares